Nutex Health (NASDAQ:NUTX) Q1 2024 Earnings Conference Call May 10, 2024 10:30 AM ET Company Participants Jennifer Rodriguez ??? Investor Relations Manager Tom Vo ??? Chairman and Chief Executive Officer Jon Bates ??? Chief Financial Officer Warren Hosseinion ??? President Josh DeTillio ??? Chief Operating Office Conference Call Participants Bill Sutherland ??? The Benchmark Company Operator Greetings and welcome to the Nutex Health First Quarter 2024 Financial Results Earnings Call. At this time, all part ...

TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1% HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION IN 2023, AN INCREASE OF 119% NET CASH FROM OPERATING ACTIVITIES OF $3.1 MILLION FOR FIRST QUARTER 2024 CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATION ...

Financial Performance - Total revenue for Q1 2024 was $67.5 million, an increase of 20% compared to $56.3 million in Q1 2023[8] - Hospital division operating income reached $10.5 million, a 119% increase from $4.8 million in the same period last year[8] - Adjusted EBITDA for Q1 2024 was $4.6 million, up 92% from $2.4 million in Q1 2023[8] - Net cash from operating activities was $3.1 million for Q1 2024, compared to $1.1 million in Q1 2023[8] - Net loss attributable to Nutex Health Inc. was $0.4 million, significantly improved from a net loss of $5.1 million in Q1 2023[8] - Net loss attributable to Nutex Health Inc. for Q1 2024 was $364,075, a significant improvement from a net loss of $5,147,279 in Q1 2023[18] - Adjusted EBITDA for Q1 2024 was $4,560,401, compared to $2,437,854 in Q1 2023, reflecting a year-over-year increase of approximately 87%[18] - EBITDA for Q1 2024 was reported at $7,111,981, a substantial increase from $320,588 in the same quarter of the previous year[18] Operational Highlights - Total hospital division visits increased to 40,068 in Q1 2024, a 21.1% rise from 33,085 visits in Q1 2023[8] - Mature hospitals contributed to a 6.7% revenue increase in 2024 compared to 2023[8] - The company opened five new micro hospitals and expanded its population health division over the past 18 months[6] - The Hospital Division operates 21 facilities across nine states, focusing on innovative healthcare models including micro-hospitals and specialty hospitals[19] - The Population Health Management division utilizes a cloud-based proprietary technology platform to aggregate clinical and claims data, enhancing care quality and efficiency[20] Financial Position - The company had $30.0 million in cash and $26.3 million in long-term debt as of March 31, 2024[6] - The balance sheet remains strong with total assets of $404.3 million as of March 31, 2024[8] Expenses and Costs - The company reported interest expense of $4,444,362 for Q1 2024, up from $3,140,089 in Q1 2023, indicating increased borrowing costs[18] - Depreciation and amortization expenses increased to $4,186,202 in Q1 2024 from $3,993,747 in Q1 2023, reflecting ongoing investments in facilities[18] - Stock-based compensation expense decreased to $49,167 in Q1 2024 from $1,900,000 in Q1 2023, indicating a reduction in equity compensation costs[18] Strategic Outlook - The company faces risks related to its growth strategy, regulatory changes, and competition, which could impact future financial performance[22] - Nutex Health Inc. is committed to expanding its provider networks and enhancing management services through its Management Services Organization (MSO)[20]

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41346 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) NUTEX HEALTH INC. (Exact name of registrant as specified in its charter) | Delaware | 11-3363609 | | -- ...

HOUSTON, May 7, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conferen ...

HOUSTON, May 6, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2024 Annual Meeting to be held on June 17, 2024 at 10:00 am Central Daylight Time via the internet as a virtual meeting only (and not in p ...

HOUSTON, April 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced its second annual private leadership conference from April 30 to May 2 in Houston, Texas.    The conference serves as an opportunity for Nutex Health leaders from across the country to gather, s ...

For the transition period from _________ to ___________ Commission file number 001-41346 NUTEX HEALTH INC. Delaware 11-3363609 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 6030 S. Rice Ave, Suite C, Houston, Texas 77081 Telephone Number (713) 660-0557 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal yea ...

Financial Performance - Total revenue for the year ended December 31, 2023, was $247.6 million, an increase of 13% compared to $219.3 million in 2022[6] - Total revenue for the fourth quarter of 2023 was $69.7 million, representing a 30% increase from $53.7 million in the same period of 2022[6] - Net loss attributable to Nutex Health Inc. for the year ended December 31, 2023, was $45.8 million, significantly improved from a net loss of $424.8 million in 2022[6] - The company reported a net loss attributable to Nutex Health Inc. of $31.6 million for the fourth quarter of 2023, compared to a net loss of $14.8 million in the fourth quarter of 2022[6] - Net income for 2023 was a loss of $43,423,715, compared to a loss of $432,739,618 in 2022, indicating a significant improvement[13] Operating Income and Expenses - Hospital division operating income increased by 142% to $36.3 million for the year ended December 31, 2023, compared to $15.0 million in 2022[6] - Adjusted EBITDA for the year ended December 31, 2023, was $10.8 million, down from $12.6 million in 2022[6] - Adjusted EBITDA for 2023 was $10,827,681, a decrease from $12,547,923 in 2022, reflecting ongoing operational challenges[16] - Cash flows from operating activities generated $1,256,452 in 2023, a substantial decline from $50,607,108 in 2022[13] - Net cash from operating activities for the year ended December 31, 2023, was $1.3 million[6] Assets and Cash Position - As of December 31, 2023, total assets were $398.2 million, down from $431.8 million in 2022[6] - Total cash and cash equivalents at the end of 2023 were $22,002,056, down from $34,255,264 at the end of 2022[13] - Net cash from investing activities was a negative $11,239,882 in 2023, compared to a negative $4,337,398 in 2022, indicating increased investment outflows[13] Strategic Initiatives - The management team initiated a strategic plan in January 2024 aimed at reducing annual cash operating expenses and optimizing resource allocation[6] - The company aims to deliver profitability on a net income basis to its investors in the medium and long term[7] - The company anticipates challenges in executing its growth strategy due to economic conditions and regulatory changes[20] Divisional Highlights - The Hospital Division operates 20 facilities across 8 states, focusing on innovative healthcare models[17] - The Population Health Management division utilizes a cloud-based technology platform to enhance patient care efficiency[18] Impairments and Financing - The company reported an impairment of assets totaling $29,082,203 in 2023, compared to no impairments in 2022[16] - Proceeds from notes payable in 2023 amounted to $16,952,905, a significant increase from $815,881 in 2022[13]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 of incorporation or organization) Identification No.) or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41346 NUTEX HEALTH INC. (Exact name of registrant a ...